Singlera Genomics Inc., a biotechnology company founded in 2014, provides molecular genetic testing for cancer and genetic diseases.
Founded in 2014 and based in Shanghai, China, Singlera Genomics Inc. is a biotechnology company providing genetic testing for cancer and genetic diseases. It has research centers in Shanghai and San Diego, and production bases in Yangzhou and Taizhou. Its tests cover risk assessment, early screening and diagnosis, medication guidance and postoperative monitoring for colorectal, liver and stomach cancers. In June 2024, the company raised strategic investment of more than CNY 100 million. It is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in